Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Beta-Blocker Interruption or Continuation after Myocardial Infarction
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular functionâ€”a prespecified substudy from REDUCE-AMI
Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
Impact of left ventricular ejection fraction on the effect of beta-blocker therapy on 1-year mortality in acute coronary syndrome patients
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
